DEC 02, 2019 05:41 PM PST

Self-renewing blood stem cells give hope for blood disease treatments

New research details how activating a certain protein may be the key to getting hematopoietic stem cells (HSCs) to self-renew. The research comes from scientists at UCLA and was published recently in Nature. Its findings may open doorways for leukemia treatment, as well as other blood diseases.

HSCs are blood stem cells found in the bone marrow that make blood by differentiating into cells like red blood cells, T and B lymphocytes, and white blood cells. HSCs play an infinitely important role in making billions of new blood cells in the human body every day.

But for people with blood diseases, HSCs are necessary to make new blood cells, a demand which has typically been met with a supply of bone marrow. However, due to the array of difficulties that come along with bone marrow transplants, some researchers have been looking into using cultured HSCs to replace bone marrow transplants. Yet, they keep on getting stumped because HSCs lose their capacity for self-renewal in cultures soon after being removed from bone marrow.

"Although we've learned a lot about the biology of these cells over the years, one key challenge has remained: making [HSCs] self-renew in the lab. We have to overcome this obstacle to move the field forward," explains senior study author Hanna K. A. Mikkola, a professor of molecular, cell, and developmental biology at UCLA.

That’s why this study’s finding of a protein called MLLT3 is so noteworthy. Mikkola and her team found that manipulating MLLT3 resulted in a "more than 12-fold expansion of transplantable" HSCs. "If we think about the amount of blood stem cells needed to treat a patient, that's a significant number," commented Mikkola. The researchers plan to continue working on their process with MLLT3 in order to move from animal trials to human trials.

Sources: Nature, Medical News Today

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
DEC 14, 2019
Cell & Molecular Biology
DEC 14, 2019
New Type of CAR T-Cell Therapy Headed for Clinical Trials
Scientists have been trying to use the immune system in cancer patients' bodies to fight cancer....
DEC 14, 2019
Cancer
DEC 14, 2019
An alternative for immunotherapy-resistant cancer patients
A twist to traditional immunotherapies could help cancer patients’ immune systems better detect cancer cells, making this new system capable of targe...
DEC 14, 2019
Cell & Molecular Biology
DEC 14, 2019
Telomerase Enzyme Found to Have a Protective Role
Telomerase was thought to be active primarily in cells that divide a lot, but new research has found, however, that telomerase has another role....
DEC 14, 2019
Genetics & Genomics
DEC 14, 2019
Evaluating the Genetic Damage Caused by Cancer Treatments
Now that we know more about the impact of some cancer treatments, they can be applied optimally....
DEC 14, 2019
Cancer
DEC 14, 2019
When the numbers don't match: inaccuracy in late state breast cancer survival estimates
According to the World Health Organization, about 2.1 million women are diagnosed with breast cancer annually. It is the cancer that most affects women and...
DEC 14, 2019
Cancer
DEC 14, 2019
Inhalable nanoparticle-immunotherapy provides new hope for lung cancer
New research published in Nature Communications details the results of a study that tested inhalable nanoparticle-immunotherapy to determine its impact on ...
Loading Comments...